Baxter BioPharma Solutions


Sterile Contract Manufacturing

With over 85 years of parenteral experience, BioPharma Solutions (a business unit of Baxter) offers a variety of contract manufacturing form/fill/finish services and solutions for injectables​, designed to meet complex and traditional sterile manufacturing challenges.  In addition, we are the only CMO to offer a manufacturer-prepared, commercial-scale aseptic filling process for premixed drugs in flexible IV bags.

BioPharma Solutions provides our clients with confidence of delivery, service, and integrity​ - we know the work we do is ultimately vital to the patients you serve​.  Areas of expertise include:

  • Sterile Contract Manufacturing Solutions
    • Prefilled Syringe Filling
    • Liquid and Lyophilized Vial Filling
    • Cartridge Filling
    • Diluents for Reconstitution
    • Powder Filled Vials
    • Sterile Crystallization
  • Parenteral Delivery Systems
    • Frozen Premix System
    • Liquid Premix System
  • Drug Categories
    • Small molecules
    • Biologics
    • Vaccines
    • Cytotoxics
    • Antibody-Drug Conjugates (ADCs)
    • Highly potent compounds

The strength of Baxter's global​ network lies in efficient, quality cGMP manufacturing — enabling BioPharma Solutions to deliver cost-effective results built on best practices and operational excellence.

  • A leader in sterile contract manufacturing​, Baxter's facility in Bloomington, Indiana, USA serves client needs from clinical development through commercial launch.
  • A world-class manufacturer of oncology products​, Baxter's Halle/Westfalen, Germany facility offers dedicated clinical through commercial production.

Related resources


Best Practices in Formulation and Lyo Development

Baxter BioPharma Solutions | 13-Feb-2017 | Technical / White Paper

The ultimate goal of formulation development is a stable product. In the case of a protein product, that can be defined as delivering the correct dose,...

Pharmaceutical Development for ADCs

Pharmaceutical Development for ADCs

Baxter BioPharma Solutions | 08-Sep-2014 | Technical / White Paper

Formulation, process, and analytical development for antibody-drug conjugates, or ADCs, is complex.While the development of an aqueous solution formulation...